Product
Ametinib + Bevacizumab
1 clinical trial
1 indication
Indication
Lung CancerClinical trial
Efficacy and Safety of Ametinib Combined With Bevacizumab in First-line Treatment of Non-oligometastatic Advanced NSCLC With EGFR-mutations.Status: Recruiting, Estimated PCD: 2023-12-01